Obesity and Recovery from Acute Kidney Injury (Ob AKI): a Prospective Cohort Feasibility Study
Overview
Authors
Affiliations
Objectives: To test the methodology of recruitment, retention and data completeness in a prospective cohort recruited after a hospitalised episode of acute kidney injury (AKI), to inform a future prospective cohort study examining the effect of obesity on AKI outcomes.
Design: Feasibility study.
Setting: Single centre, multi-site UK tertiary hospital.
Participants: 101 participants (67M; 34F) with a median age of 64 (IQR 53-73) years, with and without obesity, recruited within 3 months of a hospitalised episode of AKI.
Outcome Measures: Feasibility outcomes were recruitment (>15% meeting inclusion criteria recruited), participant retention at 6 and 12 months (≥80%) and completeness of data collection. Exploratory measures included recovery from AKI (regaining >75% of pre-AKI estimated glomerular filtration rate [eGFR]) at 6 months, development or progression of chronic kidney disease (CKD) (kidney function decrease of ≥25% + rise in CKD category) at 12 months, and associations with poorer kidney outcomes.
Results: 41% of eligible patients consented to take part, exceeding the target recruitment uptake rate of 15%. Retention was 86% at 6 months and 78% at 12 months; 10 patients died and three commenced dialysis during the study. Data were 90%-100% complete. Median BMI was 27.9 kg/m (range 18.1 kg/m-54.3 kg/m). 50% of the cohort had stage 3 AKI and 49% had pre-existing CKD. 46% of the cohort met the AKI recovery definition at 6 months. At 12 months, 20/51 patients developed CKD (39%) and CKD progression occurred in 11/49 patients (22%). Post-AKI interleukin-6 and cystatin-C were associated with 12 months decline in eGFR.
Conclusions: Feasibility to conduct a long-term observational study addressing AKI outcomes associated with obesity was demonstrated. A fully powered prospective cohort study to examine the relationships between obesity and outcomes of AKI is warranted.
Seckinger D, Ritter O, Patschan D Int Urol Nephrol. 2021; 54(7):1591-1601.
PMID: 34709558 PMC: 9184428. DOI: 10.1007/s11255-021-03036-w.
Hakam N, Nabavizadeh B, Sadighian M, Holler J, Shibley P, Li K World J Surg. 2021; 45(12):3633-3642.
PMID: 34370056 PMC: 8351221. DOI: 10.1007/s00268-021-06275-1.
MacLaughlin H, Pike M, Selby N, Siew E, Chinchilli V, Guide A BMC Nephrol. 2021; 22(1):200.
PMID: 34049502 PMC: 8161937. DOI: 10.1186/s12882-021-02400-3.
Hu P, Song L, Liang H, Chen Y, Wu Y, Zhang L Nephrology (Carlton). 2021; 26(7):586-593.
PMID: 33742730 PMC: 9292395. DOI: 10.1111/nep.13878.
Prediction Models for AKI in ICU: A Comparative Study.
Qian Q, Wu J, Wang J, Sun H, Yang L Int J Gen Med. 2021; 14:623-632.
PMID: 33664585 PMC: 7921629. DOI: 10.2147/IJGM.S289671.